Anhui Huaertai Chemical Co., Ltd.

SZSE:001217.SZ

11.49 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 382.082427.944392.306474.679442.443419.687452.223482.39490.387631.375497.327558.118551.185402.897381.531354.935272.229273.111260.194
Cost of Revenue 343.261363.115335.17378.01365.464362.576406.4393.074423.536500.892425.811411.141355.305269.08251.734235.965250.605224.03213.106
Gross Profit 38.82164.82957.13696.66976.97957.11245.82389.31666.851130.48371.516146.977195.88133.817129.797118.97121.62449.08147.088
Gross Profit Ratio 0.1020.1510.1460.2040.1740.1360.1010.1850.1360.2070.1440.2630.3550.3320.340.3350.0790.180.181
Reseach & Development Expenses 12.31411.45410.82111.62616.17411.39612.3215.37316.4819.71112.91918.2915.6414.8811.43717.1117.177.6168.415
General & Administrative Expenses 34.646-2.46612.223-17.55734.154-6.0059.945-14.52827.55-2.95810.407-18.3737.852-2.82513.027-8.4716.0986.6615.752
Selling & Marketing Expenses 4.7541.8291.8031.7851.6111.5371.5691.7061.7291.151.9631.8971.381.5191.2750.36-29.761.1671.192
SG&A 39.416.11613.53317.08135.765-4.46711.513-12.82229.279-1.80812.371-16.47339.233-1.30614.302-8.112-23.6627.6317.25
Other Expenses -23.438-1.1941.231-4.9043.471-2.5881.44532.196-13.79616.0960.7972.237-0.8160.1941.539-0.5952.69500
Operating Expenses 28.27628.76424.35333.61236.89725.87925.27834.74731.96333.99926.08731.57742.28827.99826.57833.257-16.5879.60912.443
Operating Income 10.08436.06532.78263.05842.66824.70236.89189.16213.781100.29536.489117.777153.269105.594102.20785.46537.37431.3128.787
Operating Income Ratio 0.0260.0840.0840.1330.0960.0590.0820.1850.0280.1590.0730.2110.2780.2620.2680.2410.1370.1150.111
Total Other Income Expenses Net 0.8583.86.03513.1350.2510.6320.098-38.45128.5260.81821.9722.237-1.140.1941.539-0.8441.8587.8115.482
Income Before Tax 10.94239.86638.81876.19242.91925.33436.98950.71142.307101.11358.461120.014152.452105.788103.74684.8740.06939.12234.268
Income Before Tax Ratio 0.0290.0930.0990.1610.0970.060.0820.1050.0860.160.1180.2150.2770.2630.2720.2390.1470.1430.132
Income Tax Expense 1.762.1055.48817.6421.639-0.1754.05111.6256.51914.6340.04816.57921.99913.69414.13710.6365.9165.3124.487
Net Income 9.18137.76133.3358.5541.27925.5132.93739.08535.78886.47958.413103.435130.45392.09489.60974.23434.15233.80929.781
Net Income Ratio 0.0240.0880.0850.1230.0930.0610.0730.0810.0730.1370.1170.1850.2370.2290.2350.2090.1250.1240.114
EPS 0.0280.110.10.180.120.0770.0990.120.110.270.180.310.390.280.360.220.10.140.12
EPS Diluted 0.0280.110.10.180.120.0770.0990.120.110.270.180.310.390.280.360.220.10.140.12
EBITDA 7.30572.22134.78997.71342.1943.2629.72889.07816.715115.40845.406119.224153.042106.114104.87185.144.14249.26347.117
EBITDA Ratio 0.0190.1690.0890.2060.0950.1030.0220.1850.0340.1830.0910.2140.2780.2630.2750.240.1620.180.181